Crossmark

Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case–control study

Published Online: 2019-07-22

Published Print: 2019-12

Authors

Zayas-Villanueva, Omar Alejandro

Campos-Acevedo, Luis Daniel

Lugo-Trampe, José de Jesús

Hernández-Barajas, David

González-Guerrero, Juan Francisco

Noriega-Iriondo, María Fernanda

Ramírez-Sánchez, Ilse Alejandra

Martínez-de-Villarreal, Laura Elia https://orcid.org/0000-0003-1442-9089
License Information

Text and Data Mining valid from 2019-07-22

Version of Record valid from 2019-07-22
More Information

Article History

Received: 5 June 2018

Accepted: 17 July 2019

First Online: 22 July 2019

Ethics approval and consent to participate

: Institutional Review Board approval was obtained from The Bioethics Committee for Research in Health Science from the Hospital Universitario, Universidad Autónoma de Nuevo León, approved the study protocol, which was performed in accordance with the declaration of Helsinki and good clinical practices (Reference Number, GEN15–002). Written informed consent was obtained from each patient involved in this study.

: Not applicable.

: The authors declare that we have no competing interests.

Document is current